glp-1 0 Rising Costs Cited by 68% of Users as a Major Treatment Barrier GLP-1 Medications | Fact Sheets

Uterine fibroids are non-cancerous growths affecting up to 70% of women by age 50, influenced by oestrogen and progesterone

Most are administered via subcutaneous injection, with dosing frequencies ranging from twice daily to once weekly depending on the specific formulation

Key Benefits* Supports healthy muscle, tendon, and ligament function Promotes normal tissue recovery and regeneration Encourages skin health and post-activity repair Helps maintain gut lining integrity and digestive function Supports vascular health and nitric oxide pathways Promotes cellular renewal for healthy aging Helps the body respond to oxidative and environmental stressors *These statements have not been evaluated by the Food and Drug Administration

Treatment with a GLP-1 RA led to a significant improvement in the Kansas City Cardiomyopathy Questionnaire clinical summary score (KCCQ-CCS) compared with placebo (7.8 and 7.3 points, respectively) and in the 6-minute walk distance (20.3 m and 14.3 m, respectively) at the 52-week follow-up